This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Cindy Stowell realized her lifelong dream of appearing on Jeopardy! in 2016, and won six games while battling stage 4 colon cancer. Unfortunately, Cindy died just one week before her episodes aired that December. She chose to donate her winnings to the Cancer Research Institute to fund research into developing lifesaving immunotherapies for patients with colorectal cancer.
Cindy’s winning streak qualified her for the Tournament of Champions airing this week on Jeopardy!. Her fellow champions will be wearing blue ribbons to support colon cancer awareness, and host Alex Trebek will make a special announcement on Tuesday, November 7th. Update: Host Alex Trebek announced a $10,000 donation from Jeopardy! to the Cancer Research Institute in Cindy's honor.
Sam Scovill, the three-game champion who ended Cindy’s amazing run, is urging fans to make donations to the Cancer Research Institute in her memory, and Andy Saunders is donating $2 of every item sold in The Jeopardy! Fan Online Store during the month of November to CRI in her memory.
We’d like to thank Jeopardy!, their contestants, and their fans for their continued support in Cindy’s memory. If you would like to give, please visit www.cancerresearch.org/cindy-stowell
Donate for Cindy
Cupid Intimates Gives to Cancer Immunotherapy Research
Read Previous Article
Cindy Stowell Continues to Inspire
Read Next Article
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).